The Inflation Reduction Act (IRA) of 2022, signed into law on August 16, contains some of the most significant changes in healthcare regulation since the introduction of the Medicare Modernization Act of 2003. There are many healthcare-related policy changes contained in the IRA, which can be categorized into four major sections:
- Expansion of patient access to affordable insurance
- Adjustments to medication pricing and reimbursement
- Reforms to patient cost-sharing
- The indirect effects and implications of IRA price negotiations
In this CRA Insights, Rhett Johnson and Matthew Majewski briefly summarize some of the most important changes associated with the IRA and highlight implications for life science manufacturers.
